Irrespective of family history, 17% of women aged 70 years or younger with newly diagnosed high grade serous ovarian cancer (HGSOC) harbor a germline BRCA1/2 pathologic variant [9]. This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.